Health Professionals in further training
This page lists 47 references in the Main Healthy Skepticism Library relevant to health professionals in further training.
Click on the HSL (Health Skepticism Library) number for more details which may include an abstract or full text.
HSL6736
Saunders C.
Drug reps can be a useful source of information if used the right way
Australian Doctor 2006 Sep 6
http://www.australiandoctor.com.au/news/9a/0c043e9a.asp
HSL5930
Schneider JA, Arora V, Kasza K, Van Harrison R, Humphrey H.
Residents' Perceptions Over Time of Pharmaceutical Industry Interactions and Gifts and the Effect of an Educational Intervention.
Acad Med 2006 Jul 01;81(7):595-602
Link to source with long URL
HSL5942
Windish DM, Diener-West M.
A clinician-educator's roadmap to choosing and interpreting statistical tests.
J Gen Intern Med 2006 Jun 01;21(6):656-60
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1525-1497.2006.00390.x
HSL6396
Pauls MA, Ackroyd-Stolarz S.
Identifying bioethics learning needs: a survey of Canadian emergency medicine residents.
Acad Emerg Med 2006 Jun 01;13(6):645-52
http://www.aemj.org/cgi/content/full/13/6/645
HSL6114
Ali MH, Kalima P, Maxwell SR.
Failure to implement hospital antimicrobial prescribing guidelines: a comparison of two UK academic centres.
J Antimicrob Chemother 2006 May 01;57(5):959-62
http://jac.oxfordjournals.org/cgi/content/full/57/5/959
HSL5649
Hill KP.
Free lunch?
Am J Psychiatry 2006 Apr;163(4):569-70
http://ajp.psychiatryonline.org/cgi/pmidlookup?view=long&pmid=16585426
HSL5494
Boyce P.
Restoring wisdom to the practice of psychiatry.
Australas Psychiatry 2006 Mar 01;14(1):3-7
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1440-1665.2006.02241.x
HSL6399
Wen LS, McCoy C.
Response to 'Interactions between pharmaceutical representatives and doctors in training: a thematic review'.
J Gen Intern Med 2006 Jan 01;21(1):103
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1525-1497.2005.00271_4.x
HSL5381
Chabot JM.
[Studies of medical students and residents].
Rev Prat 2005 Dec 31;55(20):2281-2
HSL4035
Huang F, Et AL.
The Association of Pharmaceutical Company Promotional Spending With Resident Physician Prescribing Behavior
Academic Psychiatry 2005 Dec 1(29):500-501
http://ap.psychiatryonline.org/cgi/content/full/29/5/500
HSL5758
Huang FY, Weiss DS, Fenimore PG, Fleming AM, Haller E, Lichtmacher JE, Eisendrath SJ.
The association of pharmaceutical company promotional spending with resident physician prescribing behavior.
Acad Psychiatry 2005 Nov-Dec 01;29(5):500-1
http://ap.psychiatryonline.org/cgi/content/full/29/5/500
HSL2665
Roner L
Resident physicians not enamored with drug reps
eyeforpharma Briefing 2005 Aug 17(151)
http://www.eyeforpharma.com/index.asp?nli=o&g-p&nld=8/17/2005&news=47334
HSL2429
Adair RF, Holmgren LR.
Do drug samples influence resident prescribing behavior? A randomized trial.
Am J Med 2005 Aug;118(8):881-4
http://www.amjmed.com/article/PIIS000293430500197X/fulltext
HSL2142
Watson PY, Khandelwal AK, Musial JL, Buckley JD.
Resident and faculty perceptions of conflict of interest in medical education.
J Gen Intern Med 2005 Apr;20(4):357-9
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1525-1497.2005.04075.x
HSL1890
Mansfield PR.
Beliefs and plans of GP registrars before and after a 90 minute talk about drug promotion
Unpublished 2005 Feb 25
HSL6613
Earle L, Kelly L.
Coping strategies, depression, and anxiety among Ontario family medicine residents.
Can Fam Physician 2005 Feb 01;51:242-3
Link to source with long URL
HSL2212
Hess R, Chang CC, Conigliaro J, McNeil M.
Understanding physicians' attitudes towards hormone therapy.
Womens Health Issues 2005 Jan-Feb;15(1):31-8
http://linkinghub.elsevier.com/retrieve/pii/S1049-3867(04)00103-3
HSL1887
Randall ML, Rosenbaum JR, Rohrbaugh RM, Rosenheck RA.
Attitudes and behaviors of psychiatry residents toward pharmaceutical representatives before and after an educational intervention.
Acad Psychiatry 2005 Spr;29(1):33-9
http://ap.psychiatryonline.org/cgi/content/abstract/29/1/33
HSL1347
Wazana A, Granich A, Primeau F, Bhanji NH, Jalbert M.
Using the literature in developing McGill's guidelines for interactions between residents and the pharmaceutical industry.
Acad Med 2004 Nov;79(11):1033-40
http://www.academicmedicine.org/cgi/content/full/79/11/1033
HSL2094
Agrawal S, Saluja I, Kaczorowski J.
A prospective before-and-after trial of an educational intervention about pharmaceutical marketing.
Acad Med 2004 Nov;79(11):1046-50
http://www.academicmedicine.org/cgi/content/full/79/11/1046
HSL1351
Watkins RS, Kimberly J Jr.
What residents don't know about physician-pharmaceutical industry interactions.
Acad Med 2004 May;79(5):432-7
http://www.academicmedicine.org/cgi/content/full/79/5/432
HSL2144
Chakrabarti A, Fleisher WP, Staley D, Calhoun L.
Interactions of staff and residents with pharmaceutical industry: a survey of psychiatric training program policies.
Ann R Coll Physicians Surg Can 2002 Dec;35(8)
HSL2896
Brody H.
A matter of influence: Changing times call for changing policies on the prescence of drug company reps in residency programs
Health Affairs (Millwood). 2002 Mar-Apr;21(2):232-234
http://www.healthaffairs.org/freecontent/s28.htm
HSL2156
Glazer JL.
Pharmaceutical representatives and resident physicians.
JAMA 2002 Feb 20;287(7):844
http://jama.ama-assn.org/cgi/content/full/287/7/844
HSL2720
Schwartz TL, Kuhles DJ 2nd, Wade M, Masand PS.
Newly admitted psychiatric patient prescriptions and pharmaceutical sales visits.
Ann Clin Psychiatry 2001 Sep;13(3):159-62
Link to source with long URL
HSL2168
Steinman MA, Shlipak MG, McPhee SJ.
Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions.
Am J Med 2001 May;110(7):551-7
http://linkinghub.elsevier.com/retrieve/pii/S000293430100660X
HSL2164
Pearson S, Smith AJ, Rolfe IE, Moulds RF, Shenfield GM.
Intern Prescribing for Common Clinical Conditions.
Adv Health Sci Educ Theory Pract 2000;5(2):141-150
Link to source with long URL
HSL2140
Razack S, Arbour L, Hutcheon R.
Proposed model for interaction between residents and residency training programs, and pharmaceutical industry.
Ann R Coll Physicians Surg Can 1999 Mar;32(2):93-6
HSL720
Guyatt G.
Determining an ethical stance: Pharmaceutical industry involvement and family medicine residency training
Can Fam Physician 1997 Nov 01;43:1898-900
HSL700
Mahood S, Zagozeski C, Bradel T, Lawrence K.
Pharmaceutical policies in Canadian family medicine training. Survey of residency programs
Can Fam Physician 1997 Nov;43:1947-51
Nil
HSL2185
Shaughnessy AF, Bucci KK.
Drug samples and family practice residents.
Ann Pharmacother 1997 Nov;31(11):1296-300
HSL761
Sergeant MD, Hodgetts PG, Godwin M, Walker DM, McHenry P.
Interactions with the pharmaceutical industry: a survey of family medicine residents in Ontario.
CMAJ 1996 Nov 1;155(9):1243-
HSL2723
Spingarn RW, Berlin JA, Strom BL.
When pharmaceutical manufacturers' employees present grand rounds, what do residents remember?
Acad Med 1996 Jan;71(1):86-8
Link to source with long URL
HSL844
Hodges B.
Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks.
CMAJ 1995 Sep 1;153(5):553-9
HSL847
Guyatt G.
Guidelines for interaction with the pharmaceutical industry
CMAJ 1995;152:1041-1042
HSL6467
Danby FW.
Interacting with the pharmaceutical industry
Canadian Medical Association Journal 1994;151:732
HSL6599
Guyatt G.
Interacting with the pharmaceutical industry
Canadian Medical Association Journal 1994;151:732
HSL2190
Brotzman GL, Mark DH.
Policy recommendations for pharmaceutical representative-resident interactions.
Fam Med 1992 Aug;24(6):431-2
HSL2161
Bucci KK, Frey KA.
A description of a pharmacotherapy curriculum in a university-based family medicine program.
Ann Pharmacother 1992 Jul-Aug;26(7-8):991-4
HSL2182
Lichstein PR, Turner RC, O'Brien K.
Impact of pharmaceutical company representatives on internal medicine residency programs. A survey of residency program directors
Arch Intern Med. 1992 May;152(5):1009-13.
HSL2183
Brotzman GL, Mark DH.
Policies regulating the activities of pharmaceutical representatives in residency programs.
J Fam Pract 1992 Jan;34(1):54-7
HSL2194
Lurie N, Rich EC, Simpson DE, Meyer J, Schiedermayer DL, Goodman JL, McKinney WP.
Pharmaceutical representatives in academic medical centers: interaction with faculty and housestaff.
J Gen Intern Med 1990 May-Jun;5(3):240-3
HSL4107
Rosenthal E.
Madison Avenue medicine
Discover 1988 Oct;9(10):34-36
HSL4068
Shaughnessy AF.
Drug promotion in a family medicine training center.
JAMA 1988 Aug 19;260(7):926
HSL3564
Kushner D.
Two-thirds of RPh's & MD's object to makers' promotion of Rx drugs to the public
American Druggist 1982 Oct;186(1):14, 16, 21-22
HSL3518
Oppenheim GL, Erickson SH, Ashworth C.
The family physician's knowledge of the cost of prescribed drugs.
J Fam Pract 1981 Jun;12(6):1027-30
HSL3255
Gould D.
Can we handle modern drugs?
New Scientist 1974 May 23;62(899):460-1